Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
Haemophilusinfluenzae外膜タンパク質およびワクチン接種におけるその使用
Document Type and Number:
Japanese Patent JP4815090
Kind Code:
B2
Abstract:
This invention relates to recombinant bacterial outer membrane proteins comprising one or more LB1(f) peptides from surface-exposed loop 3 of MOMP P5 of non-typeable H. influenzae. Polynucleotides encoding these recombinant proteins are also covered. The invention also relates to a method of isolating the recombinant proteins and a vaccine composition for use in the treatment of Haemophilus influenzae infection.

More Like This:
JP5706959Double antagonist of TNF-α and IL-21 for the prevention and treatment of autoimmune diseases
WO/2020/191281MICROBIAL NANOWIRES MODIFIED TO CONTAIN PEPTIDES AND METHODS OF MAKING
WO/2024/077776USE OF ANTIBODY MUTATION METHOD FOR THERAPEUTIC ANTIBODY DRUG
Inventors:
Bartet, Frankes-Exavier, Jackes
Philip Denoel
Poolman, Yang
Tonerd, Joel
Application Number:
JP2001559850A
Publication Date:
November 16, 2011
Filing Date:
February 13, 2001
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
GlaxoSmithKline Biologicals Society Anonymous
International Classes:
C07K19/00; C12N15/09; A61K39/00; A61K39/102; A61K39/39; A61P9/00; A61P11/00; A61P27/02; A61P27/16; A61P31/00; A61P37/04; C07K14/195; C07K14/285; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N15/31; C12P21/02
Foreign References:
WO1999064067A21999-12-16
Attorney, Agent or Firm:
Yusuke Hiraki
Satoshi Fujita
Ishii Teiji



 
Previous Patent: メチオニンを製造する方法

Next Patent: JPS4815091